Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, Kazushige Kadota, Kengo Tanabe, Yoshihiro Morino, Toshihiro Tamura, Mitsuru Abe, Satoru Suwa, Yoshiaki Ito, Masakazu Kobayashi, Kazuoki Dai, Koichi Nakao, Yasuhiro Tarutani, Ryoji Taniguchi, Hideo Nishikawa, Yoshito Yamamoto, Tomohiro Yamasaki, Atsunori Okamura, Yoshihisa Nakagawa, Kenji Ando, Koichi Kobayashi, Kazuya Kawai, Kiyoshi Hibi, Takeshi Kimura
BACKGROUND: New-generation drug-eluting stents (DES) achieved technological innovations and reported clinical advantages as compared with first-generation DES in clinical trials with 3-5 years follow-up. However, detailed clinical outcome data in very long-term follow-up is still scarce. OBJECTIVES: To evaluate 10-year clinical outcomes after first- and new-generation DES implantation. METHODS: In this extende follow-up study of the RESET, which is a largest randomized trial comparing everolimus-eluting stent (EES) with Sirolimus-eluting stent (SES), the study population consisted of 2892 patients from 84 centers...
August 6, 2023: Catheterization and Cardiovascular Interventions